SIRT1 regulates Mxd1 during malignant melanoma progression-Reference-Cited by-同舟云学术

SIRT1 regulates Mxd1 during malignant melanoma progression

Published:2017-10-03 Issue:70 Volume:8 Page:114540-114553
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Meliso Fabiana M.¹,Micali Danilo¹,Silva Camila T.¹,Sabedot Thaís S.²,Coetzee Simon G.²,Koch Adrian³,Fahlbusch Fabian B.⁴,Noushmehr Houtan²,Schneider-Stock Regine³,Jasiulionis Miriam G.¹

Affiliation:

1. Ontogeny and Epigenetics Laboratory, Pharmacology Department, Universidade Federal de São Paulo - UNIFESP, São Paulo, SP, Brazil

2. Department of Genetics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil

3. Experimental Tumorpathology, Institute of Pathology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany

4. Department of Pediatrics and Adolescent Medicine, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ubiquitin‐specific protease 22 controls melanoma metastasis and vulnerability to ferroptosis through targeting SIRT1/PTEN/PI3K signaling;MedComm;2024-08

2. Identification of TUBB4A as a Prognostic Biomarker of Melanoma by Transcriptomic Data and In Vitro Experiments;Technology in Cancer Research & Treatment;2023-01

3. Updates on Organoid Model for the Study of Liver Cancer;Technology in Cancer Research & Treatment;2023-01

4. Acetylation-dependent regulation of BRAF oncogenic function;Cell Reports;2022-01

5. DNA damage, sirtuins, and epigenetic marks;Epigenetics and DNA Damage;2022